20 LATEST RESOURCES (32 INDEXED)
×
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-Steroidal Anti-Inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study · May 2023
Articles
Drug Safety
×
Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study · April 2023
Articles
Drug Safety
×
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: A Swedish Population-Based Cohort Study · April 2023
Articles
Drug Safety
×
Mortality in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study · December 2022
Articles
Drug Safety
×
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database · November 2022
Articles
Drug Safety
×
Potential Risk Factors of Drug-Related Problems in Hospital-Based Mental Health Units: A Systematic Review · November 2022
Articles
Drug Safety
×
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment · September 2022
Articles
Drug Safety
×
Industry Perspective on Artificial Intelligence/Machine Learning in Pharmacovigilance · May 2022
Articles
Drug Safety
×
Machine Learning in Causal Inference: Application in Pharmacovigilance · May 2022
Articles
Drug Safety
×
Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review · May 2022
Articles
Drug Safety
×
Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom · March 2022
Articles
Drug Safety
×
B-Blockers and the Risk of Depression: A Matched Case–Control Study · January 2022
Articles
Drug Safety
×
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports · January 2022
Articles
Drug Safety
×
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data · September 2021
Articles
Drug Safety
×
Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study · February 2021
Articles
Drug Safety
×
A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants · December 2020
Abstracts
Drug Safety
×
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review · December 2020
Articles
Drug Safety